Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Francesca Di Salvo, Nicola Caranci, Teresa Spadea, Nicolas Zengarini, Pamela Minicozzi, Hade Amash, Mario Fusco, Fabrizio Stracci, Fabio Falcini, Claudia Cirilli, Giuseppina Candela, Rosanna Cusimano, Rosario Tumino, Milena Sant for the Socioeconomic Inequalities and Oncological Outcomes Italian Working Group
Published Jul 22, 2017 · Vol. 8, No. 40 · pp. 68402-68414
Ryan C. Chai, Michelle M. McDonald, Rachael L. Terry, NataÅ¡a KovaÄić, Jenny M. Down, Jessica A. Pettitt, Sindhu T. Mohanty, Shruti Shah, Gholamreza Haffari, Jiake Xu, Matthew T. Gillespie, Michael J. Rogers, John T. Price, Peter I. Croucher, Julian M.W. Quinn
Published Jul 10, 2017 · Vol. 8, No. 40 · pp. 68047-68058
